Lyka Labs (BOM:500259) E10: ₹-4.04 (As of Mar. 2026)


BOM:500259 Lyka Labs Ltd BOM:500259
60 GF Score
Price ₹72.36
GF Value ₹127.26
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lyka Labs E10?

Lyka Labs BOM:500259 +0.78% 60 E10 is ₹-4.04 as of Mar. 2026. GuruFocus rates BOM:500259 with a GF Score™ of 60/100 and a GF Value™ of ₹127.26 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lyka Labs's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹-2.130. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹-4.04 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Lyka Labs was 10.90% per year. The lowest was 10.90% per year. And the median was 10.90% per year.

As of today (2026-07-12), Lyka Labs's current stock price is ₹72.36. Lyka Labs's E10 for the quarter that ended in Mar. 2026 was ₹-4.04. Lyka Labs's Shiller PE Ratio of today is .


Lyka Labs  (BOM:500259) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lyka Labs E10 Related Terms


Lyka Labs E10 Historical Data

* Premium members only.

The historical data trend for Lyka Labs's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lyka Labs E10 Chart

Lyka Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -5.72 -5.59 -5.15 -4.04

Lyka Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.15 -4.93 -4.26 0.00 -4.04

BOM:500259 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Lyka Labs's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lyka Labs Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lyka Labs's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lyka Labs's Shiller PE Ratio falls into.


BOM:500259
60GF Score
Lyka Labs Ltd BOM:500259
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lyka Labs E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lyka Labs's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-2.13/164.2724*164.2724
=-2.130

Current CPI (Mar. 2026) = 164.2724.

Lyka Labs Quarterly Data

per share eps CPI Adj_EPS
201506 0.000 99.841 0.000
201512 0.230 102.901 0.367
201603 -4.750 102.518 -7.611
201606 -1.890 105.961 -2.930
201609 0.210 105.961 0.326
201612 -1.320 105.196 -2.061
201703 0.820 105.196 1.280
201803 0.000 109.786 0.000
201806 -1.790 111.317 -2.642
201809 -2.300 115.142 -3.281
201812 -0.670 115.142 -0.956
201903 2.270 118.202 3.155
201906 -1.130 120.880 -1.536
201909 -1.140 123.175 -1.520
201912 -14.500 126.235 -18.869
202003 -4.530 124.705 -5.967
202006 -1.640 127.000 -2.121
202009 -2.010 130.118 -2.538
202012 -0.800 130.889 -1.004
202103 0.380 131.771 0.474
202106 6.800 134.084 8.331
202109 9.900 135.847 11.972
202112 2.110 138.161 2.509
202203 -5.260 138.822 -6.224
202206 0.200 142.347 0.231
202209 -0.140 144.661 -0.159
202212 -3.640 145.763 -4.102
202303 -1.040 146.865 -1.163
202306 -0.570 150.280 -0.623
202309 -0.160 151.492 -0.173
202312 0.530 152.924 0.569
202403 -0.585 153.035 -0.628
202406 0.400 155.789 0.422
202409 0.580 157.882 0.603
202412 0.750 158.323 0.778
202503 0.490 157.552 0.511
202506 0.250 159.755 0.257
202509 -0.940 162.289 -0.951
202512 0.000 163.281 0.000
202603 -2.130 164.272 -2.130

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹-4.04 mean?
Lyka Labs (BOM:500259) has a E10 of ₹-4.04 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lyka Labs and its competitors.
Is Lyka Labs' E10 too high?
Lyka Labs' current E10 is ₹-4.04. Overall, Lyka Labs has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lyka Labs' E10 compare to VRTX and REGN?
Lyka Labs' E10 of ₹-4.04 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Lyka Labs and its competitors. Lyka Labs's current E10 is ₹-4.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lyka Labs stock overvalued right now?
Based on GuruFocus' analysis, Lyka Labs (BOM:500259) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹127.26, compared to a current price of ₹72.36 — trading 43.1% below its estimated fair value. The current E10 is ₹-4.04. Lyka Labs' overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Lyka Labs (BOM:500259), the current E10 is ₹-4.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lyka Labs (BOM:500259) Overvalued in 2026?

Based on GuruFocus' analysis, Lyka Labs stock appears to be undervalued. The current stock price of ₹72.36 is trading 43.1% below its estimated GF Value™ of ₹127.26. GuruFocus considers Lyka Labs to be Significantly Undervalued.

Key valuation signals for BOM:500259:

  • E10: ₹-4.04
  • GF Value™: ₹127.26 vs. price of ₹72.36 (43.1% below fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the BOM:500259 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lyka Labs Business Description

Other Exchanges LYKALABS:India
Address 30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036
Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment which is pharmaceuticals. The Company has a presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.
60GF Score

Get the complete analysis for BOM:500259

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹72.36
Price
₹127.26
GF Value